News
While hydroxychloroquine (HCQ) helps reduce disease flares in lupus, its effect on renal function in patients with lupus ...
As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...
The study cohort comprised 41,095 patients with SLE, including 19,631 who received THA and 21,464 who received TKA. Overall, 30-day readmission rates were 6.1% for THA and 4.8% for TKA. Readmission ...
You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...
16d
MONTCO Today on MSNGlaxosmithkline Gets Approval for First-of-its-Kind Lupus TreatmentGlaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated in children, ...
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks.
Discoid lupus erythematosus (also called chronic cutaneous lupus erythematosus) predominantly affects adult women. Discoid lupus erythematosus on the scalp has the same appearance as discoid lupus ...
Dear Editor, Hypertrophic Discoid Lupus Erythematosus (HDLE) is a unique subgroup of Cutaneous Lupus (CL) characterized by chronic, verrucous lesions that commonly affect the head and arms. It ...
However, for individuals with lupus, HRT — particularly treatments that contain estrogen — may have specific risks, such as potential disease flares and blood clots.
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.
IN 1954 McCuistion and Schoch1 reported the case of a white newborn infant with possible discoid lupus erythematosus. So far as can be determined this is the only previous report of a child born wi ...
Geospatial disadvantage among patients with discoid lupus erythematosus (DLE) is associated with disease severity independent of race, according to study findings published in JAMA Dermatology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results